Data Foundry

Drug recalls 2024

Potassium Chloride Extended-Release Capsules — Class I drug recall D-0605-2024

Ongoing recall by Glenmark Pharmaceuticals Inc., USA, reported 2024-07-24, distributed nationwide. Failed Dissolution Specifications

Recall numberD-0605-2024
Product typeDrug
ClassificationClass I
StatusOngoing
Voluntary or mandatedVoluntary
Recalling firmGlenmark Pharmaceuticals Inc., USA, Mahwah, NJ, United States
Recall initiated2024-05-30
Classified2024-07-17
Reported by FDA2024-07-24
DistributedNationwide (US)
Quantity36,630 bottles
Reason classesspecification failure
NDC68462-0357, 68462-0357-01, 68462-0357-05, 68462-0357-90
Lot numbers17221197, 17221385, 17221386, 17221489, 17221504, 17221530, 17221561, 17221568, 17221579, 17221702, 17221704, 17221898, 17221993, 17222029, 17222278, 17222300, 17222304, 17222395, 17222589, 17222605, 17222609, 17222613, AUG-31-24, JUL-31-24, JUN-30-24, MAY-31-24, NOV-30-24, OCT-31-24

Product

Potassium Chloride Extended-Release Capsules, USP, (750 mg) 10 mEq K, 500-count bottle, Rx Only, Manufactured by: Glenmark Pharmaceuticals Ltd. Plot No. 2, Phase-2, Pharma Zone SEZ, Pithampur, Dist.-Dhar, Madhya Pradesh 454 775, India, Manufactured for: Glenmark Pharmaceuticals Inc, USA, Mahwah, NJ 07430. NDC 68462-357-05

Reason for recall

Failed Dissolution Specifications

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0605-2024. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.